Price (delayed)
$0.822
Market cap
$26.2M
P/E Ratio
0.91
Dividend/share
N/A
EPS
$0.9
Enterprise value
$47.16M
Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The
There are no recent dividends present for ORGS.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.